Investors and Media Overview
Stock Quote: ENZN
Exchange:
OT
Price:
0.30
Change (%):
down 0.00 (1.333%)
Volume:
14,321
Data as of 3:53 PM ET on Dec 8, 2017. Delayed at least 20 minutes. Provided by eSignal.

Enzon Pharmaceuticals, Inc. receives royalty revenues from existing licensing arrangements with other companies primarily related to sales of four marketed drug products, namely, PegIntron ®, Sylatron ®, Macugen ® and CIMZIA ®.